Letter

Statin guidelines should give best statin

BMJ 2006; 333 doi: 10.1136/bmj.333.7557.46 (Published 29 June 2006)
Cite this as: BMJ 2006;333:46.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Hisashi Moriguchi (moriguchi@lsbm.org), professor,
  2. Takamoto Uemura, assistant professor,
  3. Chifumi Sato, professor
  1. Laboratory for Systems Biology and Medicine, RCAST, University of Tokyo, 4-6-1, Komaba, Meguro-ku, Tokyo, Japan 153-8904
  2. Kyorin University, Tokyo
  3. Tokyo Medical and Dental University, Tokyo

    EDITOR—Manuel et al show that guidelines on statin treatment should focus on people with the highest risk of coronary heart disease.1 However, concerns about the optimal choice of statins remain.

    A recent meta-analysis (n = 71 108) of randomised controlled trials has shown that the occurrence of myalgia is less common with fluvastatin, pravastatin, and simvastatin than atorvastatin (odds …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular